Home » Clinical Trials » Search Clinical Trials
Parent Therapeutic Areas: Immunology/Infectious Diseases

Hepatitis B

California

Los Angeles : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B (CHB).

Los Angeles : Research Site:

Prevention of Recurrent Hepatitis B After Liver Transplantation

Palo Alto : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B (CHB).

San Diego : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B (CHB).

San Francisco : Research Site:

Prevention of Recurrent Hepatitis B After Liver Transplantation

San Jose : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B (CHB).

Stanford : Research Site:

Prevention of Recurrent Hepatitis B After Liver Transplantation

Florida

Miami : Research Site:

Prevention of Recurrent Hepatitis B After Liver Transplantation

Georgia

Atlanta : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B (CHB).

Atlanta : Radiant Research - Atlanta

Hepatitis B Vaccine Research

Illinois

Chicago : Radiant Research

Hepatitis B Vaccine Research Study

Various Cities : Research Center New!

Hepatitis B Study CLDT600AUS06

Louisiana

New Orleans : Research Site:

Prevention of Recurrent Hepatitis B After Liver Transplantation

Massachusetts

Boston : Research Site:

Prevention of Recurrent Hepatitis B After Liver Transplantation

Michigan

Ann Arbor : Research Site:

Prevention of Recurrent Hepatitis B After Liver Transplantation

Minnesota

Brooklyn Center : Twin Cities Clinical Research

Hepatitis B is a viral infection of the liver that can become chronic and is contagious. This virus becomes a major threat to many people, in particular to people with progressive kidney disease.

New York

Flushing : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B (CHB).

New York : Mount Sinai Medical Center

A Multi-center, Randomized, Double-Blind, Active-Control, 96 Week, Phase III Trial of the Efficacy and Safety of Clevudine Compared with Adefovir at Weeks 48 and 96 in Nucleoside Treatment-Naive Patients with HBeAg Positive Chronic Hepatitis due to Hepatitis B Virus

New York : Research Site:

Prevention of Recurrent Hepatitis B After Liver Transplantation

Rochester : Research Site:

Prevention of Recurrent Hepatitis B After Liver Transplantation

Various Cities : Research Center New!

Hepatitis B Study CLDT600AUS06

Oregon

Portland : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B (CHB).

Pennsylvania

Philadelphia : Research Site:

Prevention of Recurrent Hepatitis B After Liver Transplantation

Tennessee

Nashville : Clinical Research Associates, Inc. New!

HEPATITIS B (HBV) VACCINE

Texas

Various Cities : Research Center New!

Hepatitis B Study CLDT600AUS06

Virginia

Charlottesville : Research Site:

Prevention of Recurrent Hepatitis B After Liver Transplantation

Richmond : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B (CHB).

Richmond : Research Site:

Prevention of Recurrent Hepatitis B After Liver Transplantation

Australia

Brisbane : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B (CHB).

Fitzroy : Research Site:

A Follow-Up Study to WV19432, to Evaluate Long Term Post-Treatment Effects of PEGASYS (Peginterferon alfa-2a(40KD))in Patients With HBeAg Positive Chronic Hepatitis B

Fitzroy : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B (CHB).

Austria

Graz : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Innsbruck : Research Site:

A Study of PEGASYS plus Ribavirin Combination Therapy in Patients with HBeAg-Negative Chronic Hepatitis B Infection

Innsbruck : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Linz : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Vienna : Research Site:

A Study of PEGASYS plus Ribavirin Combination Therapy in Patients with HBeAg-Negative Chronic Hepatitis B Infection

Wien : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Bahrain

Manama : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Bangladesh

Dhaka : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Brazil

Campinas : Research Site:

A Follow-Up Study to WV19432, to Evaluate Long Term Post-Treatment Effects of PEGASYS (Peginterferon alfa-2a(40KD))in Patients With HBeAg Positive Chronic Hepatitis B

Campinas : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B (CHB).

Ribeirão Preto : Research Site:

A Follow-Up Study to WV19432, to Evaluate Long Term Post-Treatment Effects of PEGASYS (Peginterferon alfa-2a(40KD))in Patients With HBeAg Positive Chronic Hepatitis B

Ribeirão Preto : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B (CHB).

Salvador : Research Site:

A Follow-Up Study to WV19432, to Evaluate Long Term Post-Treatment Effects of PEGASYS (Peginterferon alfa-2a(40KD))in Patients With HBeAg Positive Chronic Hepatitis B

Salvador : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B (CHB).

Santo Andre : Research Site:

A Follow-Up Study to WV19432, to Evaluate Long Term Post-Treatment Effects of PEGASYS (Peginterferon alfa-2a(40KD))in Patients With HBeAg Positive Chronic Hepatitis B

Santo Andre : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B (CHB).

Sao Paulo : Research Site:

A Follow-Up Study to WV19432, to Evaluate Long Term Post-Treatment Effects of PEGASYS (Peginterferon alfa-2a(40KD))in Patients With HBeAg Positive Chronic Hepatitis B

Sao Paulo : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B (CHB).

Bulgaria

Plovdiv : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg-Negative Chronic Hepatitis B Virus (HBV)

Sofia : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg-Negative Chronic Hepatitis B Virus (HBV)

Sofia : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Sofia : Research Site:

SOFIA-LTT Study: A Study of Intermittent Long Term Treatment With PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg Negative Chronic Hepatitis B (CHB).

Stara Zagora : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg-Negative Chronic Hepatitis B Virus (HBV)

Varna : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg-Negative Chronic Hepatitis B Virus (HBV)

Varna : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

China

Beijing : Research Site:

A Follow-Up Study to WV19432, to Evaluate Long Term Post-Treatment Effects of PEGASYS (Peginterferon alfa-2a(40KD))in Patients With HBeAg Positive Chronic Hepatitis B

Beijing : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B (CHB).

Beijing : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With Lamivudine-Resistant HBeAg-Positive Chronic Hepatitis B (HBV).

Beijing : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) Plus Entecavir in Treatment-Naive Patients With HBeAg-Positive Chronic Hepatitis B.

Beijing : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a(40KD)) in Patients With HBeAg-Positive Chronic Hepatitis B Virus (HBV).

Beijing : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Bejing : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Chengdu : Research Site:

A Study of Combination or Sequential Treatment With PEGASYS (peginterferon alfa-2a (40KD))and Entecavir in Patients With HBeAg Positive Chronic Hepatitis B

Chengdu : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Chongqing : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With Lamivudine-Resistant HBeAg-Positive Chronic Hepatitis B (HBV).

Chongqing : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Fu Zhou : Research Site:

A Study of Combination or Sequential Treatment With PEGASYS (peginterferon alfa-2a (40KD))and Entecavir in Patients With HBeAg Positive Chronic Hepatitis B

Guangzhou : Research Site:

A Follow-Up Study to WV19432, to Evaluate Long Term Post-Treatment Effects of PEGASYS (Peginterferon alfa-2a(40KD))in Patients With HBeAg Positive Chronic Hepatitis B

Guangzhou : Research Site:

A Study of Combination or Sequential Treatment With PEGASYS (peginterferon alfa-2a (40KD))and Entecavir in Patients With HBeAg Positive Chronic Hepatitis B

Guangzhou : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B (CHB).

Guangzhou : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With Lamivudine-Resistant HBeAg-Positive Chronic Hepatitis B (HBV).

Guangzhou : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a(40KD)) in Patients With HBeAg-Positive Chronic Hepatitis B Virus (HBV).

Guangzhou : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Hang Zhou : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Hangzhou : Research Site:

A Study of Combination or Sequential Treatment With PEGASYS (peginterferon alfa-2a (40KD))and Entecavir in Patients With HBeAg Positive Chronic Hepatitis B

Hangzhou : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With Lamivudine-Resistant HBeAg-Positive Chronic Hepatitis B (HBV).

Hangzhou : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) Plus Entecavir in Treatment-Naive Patients With HBeAg-Positive Chronic Hepatitis B.

Hangzhou : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Harbin : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

He Fei : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Hunan : Research Site:

A Follow-Up Study to WV19432, to Evaluate Long Term Post-Treatment Effects of PEGASYS (Peginterferon alfa-2a(40KD))in Patients With HBeAg Positive Chronic Hepatitis B

Hunan : Research Site:

A Study of Combination or Sequential Treatment With PEGASYS (peginterferon alfa-2a (40KD))and Entecavir in Patients With HBeAg Positive Chronic Hepatitis B

Hunan : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B (CHB).

Jinan : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With Lamivudine-Resistant HBeAg-Positive Chronic Hepatitis B (HBV).

Jinan : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Nan Jing : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Shanghai : Research Site:

A Follow-Up Study to WV19432, to Evaluate Long Term Post-Treatment Effects of PEGASYS (Peginterferon alfa-2a(40KD))in Patients With HBeAg Positive Chronic Hepatitis B

Shanghai : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B (CHB).

Shanghai : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With Lamivudine-Resistant HBeAg-Positive Chronic Hepatitis B (HBV).

Shanghai : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) Plus Entecavir in Treatment-Naive Patients With HBeAg-Positive Chronic Hepatitis B.

Shanghai : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a(40KD)) in Patients With HBeAg-Positive Chronic Hepatitis B Virus (HBV).

Shanghai : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Shen Yang : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Shen Zhen : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Shi Jiazhuang : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Urumchi : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Wen Zhou : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Wuhan : Research Site:

A Study of Combination or Sequential Treatment With PEGASYS (peginterferon alfa-2a (40KD))and Entecavir in Patients With HBeAg Positive Chronic Hepatitis B

Xi'An : Research Site:

A Study of Combination or Sequential Treatment With PEGASYS (peginterferon alfa-2a (40KD))and Entecavir in Patients With HBeAg Positive Chronic Hepatitis B

Xi'An : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) Plus Entecavir in Treatment-Naive Patients With HBeAg-Positive Chronic Hepatitis B.

Xi'An : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Zhengzhou : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) Plus Entecavir in Treatment-Naive Patients With HBeAg-Positive Chronic Hepatitis B.

Estonia

Tallinn : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg-Positive Chronic Hepatitis B (CHB).

Tartu : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg-Positive Chronic Hepatitis B (CHB).

France

Aix en Provence : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Amiens : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Angers : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Argenteuil : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Avignon : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Besancon : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Bobigny : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Bondy : Research Site:

A Pilot Study of New-Onset Therapy With PEGASYS (Peginterferon alfa-2a (40KD)) in Pre-Treated Patients With Chronic Hepatitis B.

Bondy : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Bordeaux : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Bourgoin Jallieu : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Brest : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Caen : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Chambray Les Tours : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Chambray-Lès-Tours : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Clamart : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Clermont-Ferrand : Research Site:

A Pilot Study of New-Onset Therapy With PEGASYS (Peginterferon alfa-2a (40KD)) in Pre-Treated Patients With Chronic Hepatitis B.

Clermont-Ferrand : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Clichy : Research Site:

A Pilot Study of New-Onset Therapy With PEGASYS (Peginterferon alfa-2a (40KD)) in Pre-Treated Patients With Chronic Hepatitis B.

Clichy : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B (CHB).

Clichy : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Corbeil-Essonnes : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Creil : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Creteil : Research Site:

A Pilot Study of New-Onset Therapy With PEGASYS (Peginterferon alfa-2a (40KD)) in Pre-Treated Patients With Chronic Hepatitis B.

Creteil : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Dijon : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Gonesse : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Grasse : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Grenoble : Research Site:

A Pilot Study of New-Onset Therapy With PEGASYS (Peginterferon alfa-2a (40KD)) in Pre-Treated Patients With Chronic Hepatitis B.

Grenoble : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Lagny Sur Marne : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Le Kremlin-Bicetre : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Le Mans : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Lille : Research Site:

A Pilot Study of New-Onset Therapy With PEGASYS (Peginterferon alfa-2a (40KD)) in Pre-Treated Patients With Chronic Hepatitis B.

Lille : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Limoges : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Lyon : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Marseille : Research Site:

A Pilot Study of New-Onset Therapy With PEGASYS (Peginterferon alfa-2a (40KD)) in Pre-Treated Patients With Chronic Hepatitis B.

Marseille : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Metz : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Montauban : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Montivilliers : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Montpellier : Research Site:

A Pilot Study of New-Onset Therapy With PEGASYS (Peginterferon alfa-2a (40KD)) in Pre-Treated Patients With Chronic Hepatitis B.

Montpellier : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B (CHB).

Montpellier : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Mulhouse : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Nantes : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Nice : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B (CHB).

Nimes : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Niort : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Orleans : Research Site:

A Pilot Study of New-Onset Therapy With PEGASYS (Peginterferon alfa-2a (40KD)) in Pre-Treated Patients With Chronic Hepatitis B.

Orleans : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Paris : Research Site:

A Pilot Study of New-Onset Therapy With PEGASYS (Peginterferon alfa-2a (40KD)) in Pre-Treated Patients With Chronic Hepatitis B.

Paris : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Perpignan : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Pessac : Research Site:

A Pilot Study of New-Onset Therapy With PEGASYS (Peginterferon alfa-2a (40KD)) in Pre-Treated Patients With Chronic Hepatitis B.

Pessac : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Quimper : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Reims : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Rennes : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Rouen : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Saint Laurent Du Var : Research Site:

A Pilot Study of New-Onset Therapy With PEGASYS (Peginterferon alfa-2a (40KD)) in Pre-Treated Patients With Chronic Hepatitis B.

Saint Laurent Du Var : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

St Maurice : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Strasbourg : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B (CHB).

Strasbourg : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Toulon : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Toulouse : Research Site:

A Pilot Study of New-Onset Therapy With PEGASYS (Peginterferon alfa-2a (40KD)) in Pre-Treated Patients With Chronic Hepatitis B.

Toulouse : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B (CHB).

Toulouse : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Vandoeuvre-Les-Nancy : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Villejuif : Research Site:

A Pilot Study of New-Onset Therapy With PEGASYS (Peginterferon alfa-2a (40KD)) in Pre-Treated Patients With Chronic Hepatitis B.

Villejuif : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B (CHB).

Villejuif : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Germany

Berlin : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B (CHB).

Berlin : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Bonn : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Düsseldorf : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Essen : Research Site:

A Study of PEGASYS plus Ribavirin Combination Therapy in Patients with HBeAg-Negative Chronic Hepatitis B Infection

Frankfurt Am Main : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B (CHB).

Frankfurt Am Main : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Freiburg : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B (CHB).

Freiburg : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Giessen : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Hamburg : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Hamm : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Hannover : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Heidelberg : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Herne : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Homburg : Research Site:

A Study of PEGASYS plus Ribavirin Combination Therapy in Patients with HBeAg-Negative Chronic Hepatitis B Infection

Jena : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Kiel : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Köln : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B (CHB).

Lübeck : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Mainz : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

München : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Oberhausen : Research Site:

A Study of PEGASYS plus Ribavirin Combination Therapy in Patients with HBeAg-Negative Chronic Hepatitis B Infection

Offenburg : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Stuttgart : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Ulm : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Greece

Aigaleo - Attiki : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a(40KD)) in Patients With Chronic Hepatitis B Virus (HBV)

Alexandroupolis : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a(40KD)) in Patients With Chronic Hepatitis B Virus (HBV)

Athens : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a(40KD)) in Patients With Chronic Hepatitis B Virus (HBV)

Athens : Research Site:

A Study of PEGASYS plus Ribavirin Combination Therapy in Patients with HBeAg-Negative Chronic Hepatitis B Infection

Piraeus : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a(40KD)) in Patients With Chronic Hepatitis B Virus (HBV)

Thessaloniki : Research Site:

A Study of PEGASYS plus Ribavirin Combination Therapy in Patients with HBeAg-Negative Chronic Hepatitis B Infection

Hong Kong

Hong Kong : Research Site:

A Follow-Up Study to WV19432, to Evaluate Long Term Post-Treatment Effects of PEGASYS (Peginterferon alfa-2a(40KD))in Patients With HBeAg Positive Chronic Hepatitis B

Hong Kong : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B (CHB).

Hong Kong : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With Lamivudine-Resistant HBeAg-Positive Chronic Hepatitis B (HBV).

Hong Kong : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) Plus Entecavir in Treatment-Naive Patients With HBeAg-Positive Chronic Hepatitis B.

Hong Kong : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

India

Guwahati : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Mumbai : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

New Delhi : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Pune : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Trivandrum : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Indonesia

Bandung : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Jakarta : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Surabaya : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Tangerang : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Ireland

Dublin : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Italy

Augusta : Research Site:

A Study of PEGASYS plus Ribavirin Combination Therapy in Patients with HBeAg-Negative Chronic Hepatitis B Infection

Bari : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg-Negative Chronic Hepatitis B Virus (HBV)

Bologna : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With Chronic Hepatitis B Virus (HBV) Infection-Immunology Sub-Study of ML18253

Bologna : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg-Negative Chronic Hepatitis B Virus (HBV)

Brescia : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg-Negative Chronic Hepatitis B Virus (HBV)

Cagliari : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg-Negative Chronic Hepatitis B Virus (HBV)

Caserta : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg-Negative Chronic Hepatitis B Virus (HBV)

Castellana Grotte : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg-Negative Chronic Hepatitis B Virus (HBV)

Catania : Research Site:

A Study of PEGASYS plus Ribavirin Combination Therapy in Patients with HBeAg-Negative Chronic Hepatitis B Infection

Galatina : Research Site:

A Study of PEGASYS plus Ribavirin Combination Therapy in Patients with HBeAg-Negative Chronic Hepatitis B Infection

Messina : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg-Negative Chronic Hepatitis B Virus (HBV)

Messina : Research Site:

A Study of PEGASYS plus Ribavirin Combination Therapy in Patients with HBeAg-Negative Chronic Hepatitis B Infection

Milano : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With Chronic Hepatitis B Virus (HBV) Infection-Immunology Sub-Study of ML18253

Milano : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg-Negative Chronic Hepatitis B Virus (HBV)

Napoli : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg-Negative Chronic Hepatitis B Virus (HBV)

Padova : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg-Negative Chronic Hepatitis B Virus (HBV)

Palermo : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg-Negative Chronic Hepatitis B Virus (HBV)

Palermo : Research Site:

A Study of PEGASYS plus Ribavirin Combination Therapy in Patients with HBeAg-Negative Chronic Hepatitis B Infection

Parma : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With Chronic Hepatitis B Virus (HBV) Infection-Immunology Sub-Study of ML18253

Parma : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg-Negative Chronic Hepatitis B Virus (HBV)

Pisa : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg-Negative Chronic Hepatitis B Virus (HBV)

San Giovanni Rotondo : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg-Negative Chronic Hepatitis B Virus (HBV)

Torino : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg-Negative Chronic Hepatitis B Virus (HBV)

Udine : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg-Negative Chronic Hepatitis B Virus (HBV)

Verona : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg-Negative Chronic Hepatitis B Virus (HBV)

Jordan

Amman : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Irbid : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Korea, Republic of

Anyang : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Busan : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Chooncheon : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Daegu : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Daejeon : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Incheon : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Jeonju : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Seoul : Research Site:

A Follow-Up Study to WV19432, to Evaluate Long Term Post-Treatment Effects of PEGASYS (Peginterferon alfa-2a(40KD))in Patients With HBeAg Positive Chronic Hepatitis B

Seoul : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Seoungnamsi : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Ulsan : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Latvia

Riga : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg-Positive Chronic Hepatitis B (CHB).

Lebanon

Beirut : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Lithuania

Kaunas : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg-Positive Chronic Hepatitis B (CHB).

Klaipeda : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg-Positive Chronic Hepatitis B (CHB).

Vilnius : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg-Positive Chronic Hepatitis B (CHB).

Macedonia, The Former Yugoslav Republic of

Skopje : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Morocco

Casablanca : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Fes : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Rabat : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Netherlands

Rotterdam : Research Site:

A Study of PEGASYS plus Ribavirin Combination Therapy in Patients with HBeAg-Negative Chronic Hepatitis B Infection

New Zealand

Auckland : Research Site:

A Follow-Up Study to WV19432, to Evaluate Long Term Post-Treatment Effects of PEGASYS (Peginterferon alfa-2a(40KD))in Patients With HBeAg Positive Chronic Hepatitis B

Auckland : Research Site:

A Study of Early Immunologic Response in Asian Patients with Chronic Hepatitis B, Treated With Pegasys (Peginterferon alfa-2a (40KD)), Nucleoside Analogues, or Both

Auckland : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With Chronic Hepatitis B Virus (HBV) in an Expanded Access Program

Auckland : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B (CHB).

Auckland : Research Site:

A Study of Pegasys Monotherapy in Patients With Chronic Hepatitis B Who Have Participated in Previous Studies

Auckland : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Christchurch : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With Chronic Hepatitis B Virus (HBV) in an Expanded Access Program

Hamilton : Research Site:

A Follow-Up Study to WV19432, to Evaluate Long Term Post-Treatment Effects of PEGASYS (Peginterferon alfa-2a(40KD))in Patients With HBeAg Positive Chronic Hepatitis B

Hamilton : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With Chronic Hepatitis B Virus (HBV) in an Expanded Access Program

Hamilton : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B (CHB).

Hamilton : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

New Plymouth : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With Chronic Hepatitis B Virus (HBV) in an Expanded Access Program

Rotorua : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With Chronic Hepatitis B Virus (HBV) in an Expanded Access Program

Whakatane : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Poland

Bialystok : Research Site:

A Study of PEGASYS plus Ribavirin Combination Therapy in Patients with HBeAg-Negative Chronic Hepatitis B Infection

Bialystok : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Bydgoszcz : Research Site:

A Study of PEGASYS plus Ribavirin Combination Therapy in Patients with HBeAg-Negative Chronic Hepatitis B Infection

Bydgoszcz : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Chorzow : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Krakow : Research Site:

A Study of PEGASYS plus Ribavirin Combination Therapy in Patients with HBeAg-Negative Chronic Hepatitis B Infection

Poznan : Research Site:

A Study of PEGASYS plus Ribavirin Combination Therapy in Patients with HBeAg-Negative Chronic Hepatitis B Infection

Warszawa : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Wroclaw : Research Site:

A Study of PEGASYS plus Ribavirin Combination Therapy in Patients with HBeAg-Negative Chronic Hepatitis B Infection

Romania

Bucharest : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg-Positive Chronic Hepatitis B Virus (HBV)

Bucharest : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Cluj-Napoca : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg-Positive Chronic Hepatitis B Virus (HBV)

Constanta : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg-Positive Chronic Hepatitis B Virus (HBV)

Iasi : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg-Positive Chronic Hepatitis B Virus (HBV)

Timisoara : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg-Positive Chronic Hepatitis B Virus (HBV)

Timisoara : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Russian Federation

Chelyabinsk : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With Chronic Hepatitis B.

Ekaterinburg : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With Chronic Hepatitis B.

Irkutsk : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With Chronic Hepatitis B.

Kazan : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With Chronic Hepatitis B.

Krasnoyarsk : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With Chronic Hepatitis B.

Moscow : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With Chronic Hepatitis B.

Nizhny Novgorod : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With Chronic Hepatitis B.

Novokuznetsk : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With Chronic Hepatitis B.

Novosibirsk : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With Chronic Hepatitis B.

Rostov-Na-Donu : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With Chronic Hepatitis B.

Samara : Research Site:

A Follow-Up Study to WV19432, to Evaluate Long Term Post-Treatment Effects of PEGASYS (Peginterferon alfa-2a(40KD))in Patients With HBeAg Positive Chronic Hepatitis B

Samara : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With Chronic Hepatitis B.

Samara : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B (CHB).

Smolensk : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B (CHB).

St Petersburg : Research Site:

A Follow-Up Study to WV19432, to Evaluate Long Term Post-Treatment Effects of PEGASYS (Peginterferon alfa-2a(40KD))in Patients With HBeAg Positive Chronic Hepatitis B

St Petersburg : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With Chronic Hepatitis B.

St Petersburg : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B (CHB).

Stavropol : Research Site:

A Follow-Up Study to WV19432, to Evaluate Long Term Post-Treatment Effects of PEGASYS (Peginterferon alfa-2a(40KD))in Patients With HBeAg Positive Chronic Hepatitis B

Stavropol : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With Chronic Hepatitis B.

Stavropol : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B (CHB).

Tomsk : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With Chronic Hepatitis B.

Tumen : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With Chronic Hepatitis B.

Ufa : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With Chronic Hepatitis B.

Volgograd : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With Chronic Hepatitis B.

Yakutsk : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With Chronic Hepatitis B.

Saudi Arabia

Riyadh : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Tabuk : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Singapore

Singapore : Research Site:

A Follow-Up Study to WV19432, to Evaluate Long Term Post-Treatment Effects of PEGASYS (Peginterferon alfa-2a(40KD))in Patients With HBeAg Positive Chronic Hepatitis B

Singapore : Research Site:

A Study of Early Immunologic Response in Asian Patients with Chronic Hepatitis B, Treated With Pegasys (Peginterferon alfa-2a (40KD)), Nucleoside Analogues, or Both

Singapore : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B (CHB).

Singapore : Research Site:

A Study of Pegasys Monotherapy in Patients With Chronic Hepatitis B Who Have Participated in Previous Studies

Taiwan

Changhua : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Combination With Adefovir or Entecavir in Patients With HBeAg-Positive Chronic Hepatitis B

Kaohsiung : Research Site:

A Follow-Up Study to WV19432, to Evaluate Long Term Post-Treatment Effects of PEGASYS (Peginterferon alfa-2a(40KD))in Patients With HBeAg Positive Chronic Hepatitis B

Kaohsiung : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Combination With Adefovir or Entecavir in Patients With HBeAg-Positive Chronic Hepatitis B

Kaohsiung : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B (CHB).

Taichung : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Combination With Adefovir or Entecavir in Patients With HBeAg-Positive Chronic Hepatitis B

Taipei : Research Site:

A Follow-Up Study to WV19432, to Evaluate Long Term Post-Treatment Effects of PEGASYS (Peginterferon alfa-2a(40KD))in Patients With HBeAg Positive Chronic Hepatitis B

Taipei : Research Site:

A Study of Early Immunologic Response in Asian Patients with Chronic Hepatitis B, Treated With Pegasys (Peginterferon alfa-2a (40KD)), Nucleoside Analogues, or Both

Taipei : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Combination With Adefovir or Entecavir in Patients With HBeAg-Positive Chronic Hepatitis B

Taipei : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B (CHB).

Taipei : Research Site:

A Study of Pegasys Monotherapy in Patients With Chronic Hepatitis B Who Have Participated in Previous Studies

Taoyuan : Research Site:

A Follow-Up Study to WV19432, to Evaluate Long Term Post-Treatment Effects of PEGASYS (Peginterferon alfa-2a(40KD))in Patients With HBeAg Positive Chronic Hepatitis B

Taoyuan : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Combination With Adefovir or Entecavir in Patients With HBeAg-Positive Chronic Hepatitis B

Taoyuan : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B (CHB).

Thailand

Bangkok : Research Site:

A Follow-Up Study to WV19432, to Evaluate Long Term Post-Treatment Effects of PEGASYS (Peginterferon alfa-2a(40KD))in Patients With HBeAg Positive Chronic Hepatitis B

Bangkok : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B (CHB).

Bangkok : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Chiang Mai : Research Site:

A Follow-Up Study to WV19432, to Evaluate Long Term Post-Treatment Effects of PEGASYS (Peginterferon alfa-2a(40KD))in Patients With HBeAg Positive Chronic Hepatitis B

Chiang Mai : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B (CHB).

Chiang Mai : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Khon Kaen : Research Site:

A Follow-Up Study to WV19432, to Evaluate Long Term Post-Treatment Effects of PEGASYS (Peginterferon alfa-2a(40KD))in Patients With HBeAg Positive Chronic Hepatitis B

Khon Kaen : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B (CHB).

Songkhla : Research Site:

A Follow-Up Study to WV19432, to Evaluate Long Term Post-Treatment Effects of PEGASYS (Peginterferon alfa-2a(40KD))in Patients With HBeAg Positive Chronic Hepatitis B

Songkhla : Research Site:

A Study of PEGASYS (Peginterferon alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B (CHB).

Songkhla : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Turkey

Ankara : Research Site:

A Study of PEGASYS plus Ribavirin Combination Therapy in Patients with HBeAg-Negative Chronic Hepatitis B Infection

Ankara : Research Site:

ADVANCE Study: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) + Adefovir Dipivoxil in Patients With Hbe(-) Chronic Hepatitis B

Ege : Research Site:

A Study of PEGASYS plus Ribavirin Combination Therapy in Patients with HBeAg-Negative Chronic Hepatitis B Infection

Gaziantep : Research Site:

ADVANCE Study: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) + Adefovir Dipivoxil in Patients With Hbe(-) Chronic Hepatitis B

Istanbul : Research Site:

A Study of PEGASYS plus Ribavirin Combination Therapy in Patients with HBeAg-Negative Chronic Hepatitis B Infection

United Kingdom

London : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys

Manchester : Research Site:

An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys